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ABSTRACT 24 
Corynebacterium spp. are rarely considered as pathogens but data in orthopedic 25 
infections are sparse. Therefore, we asked how often Corynebacterium spp. caused 26 
an infection in a defined cohort of orthopedic patients with a positive culture. In 27 
addition, we aimed to determine the species variety and susceptibility of isolated 28 
strains in regards to potential treatment strategies. Between 2006 and 2015, we 29 
retrospectively assessed all Corynebacterium sp. bone and joint cultures from an 30 
orthopedic ward. The isolates were considered as relevant indicating an infection if 31 
the same Corynebacterium sp. was present in at least two samples. We found 97 32 
orthopedic cases with isolation of Corynebacterium spp. (128 positive samples), 33 
mainly Corynebacterium tuberculostearicum (n=26), Corynebacterium amycolatum 34 
(n=17), Corynebacterium striatum (n=13), and Corynebacterium afermentans (n=11). 35 
Compared to a cohort of positive blood cultures, we found significantly more C. 36 
striatum and C. tuberculostearicum but no C. jeikeium cases. Only 16 cases out 66 37 
cases (24.2%) with an available diagnostic set of at least 2 samples had an infection. 38 
Antibiotic susceptibility testing (AST) of different antibiotics showed various 39 
susceptibility results except for vancomycin and linezolid with a 100% susceptibility 40 
rate. Rates of susceptibility of corynebacteria isolated from orthopedic samples and 41 
of isolates from blood cultures were comparable. In conclusion, our study results 42 
confirmed that Corynebacterium sp. is most often isolated as a contaminant in a 43 
cohort of orthopedic patients. AST is necessary to define the optimal treatment in 44 
orthopedic infections. 45 
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INTRODUCTION 46 
Orthopedic infections, including septic arthritis of a native joint, periprosthetic joint 47 
infections (PJI), and osteomyelitis, are typically treated in specialized orthopedic 48 
centers. Most of these infections are chronic, and they are difficult to diagnose and to 49 
treat due to biofilm formation (1). A definitive criterion for orthopedic infections is 50 
growth of the same pathogen in at least two diagnostic samples or presence of a 51 
sinus tract in implant-associated infections (2, 3). The significance of a single 52 
positive sample of skin commensals such as coagulase-negative staphylococci, 53 
Cutibacterium species (formerly Propionibacterium species) species, or 54 
Corynebacterium species is not fully clear and often considered a contamination of 55 
the sample.  56 
The spectrum of human infections with corynebacteria is broad ranging from 57 
community-acquired infections such as conjunctivitis, pharyngitis, genitourinary tract 58 
infections, prostatitis, skin and soft-tissue infections, and breast abscess to 59 
nosocomial acquired infections such as cerebrospinal fluid shunt infections, 60 
pneumonia, intravenous catheter-related bloodstream infections, endocarditis, 61 
postsurgical infections, urinary tract infections, and peritoneal dialysis-related 62 
peritonitis (4-12). The spectrum of Corynebacterium spp. orthopedic infections has 63 
not been described so far. In this study, we report the spectrum of Corynebacterium 64 
spp. isolates of suspected orthopedic infections and compare it with the spectrum of 65 
species isolated from patients with suspected blood-stream infections. We 66 
discriminated between infections and contaminants based on clinical and 67 
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microbiological criteria and present antibiotic susceptibility data to describe treatment 68 
options. 69 
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METHODS 70 
Orthopedic study population 71 
The orthopedic University Hospital Balgrist in Zurich, Switzerland is a 140-bed 72 
orthopedic center. Approximately 5000 orthopedic procedures are performed 73 
annually. In this single-center study, we retrospectively identified patients with at 74 
least one culture positive sample with Corynebacterium spp. derived from synovial 75 
fluid, deep tissue/bone, or sonication fluid from removed implants between January 76 
2006 and December 2015. Bacteria labeled as “coryneform bacteria”, i.e., aerobic 77 
Actinomyces spp., Brevibacterium spp., Dermabacter hominis, Lactobacillus spp., 78 
Cutibacterium (Propionibacterium) spp., and other Gram-positive rods, which were 79 
not further characterized, were excluded from our analysis. The latter were found 80 
only in single samples in a small amount or in mixed cultures. Cases with lack of 81 
clinical data were excluded for our investigation (Figure 1). 82 
Species variation of Corynebacterium spp. in suspected orthopedic infections 83 
compared to blood-stream infections outside orthopedic wards. We compared 84 
the various isolated Corynebacterium spp. from orthopedic origins with isolates 85 
recovered from blood cultures (from January 2006 to December 2015) in patients 86 
with suspected bloodstream infections hospitalized in non-orthopedic wards of the 87 
University Hospital of Zurich, Switzerland, with a wide range of medical specialties 88 
(e.g., ophthalmology, urology, gynecology, neurosurgery, vascular and heart 89 
surgery, dermatology, internal medicine, oncology). 90 
Clinical diagnosis. All samples of the same patient, the same hospitalization period, 91 
and the same infection site were considered as one diagnostic set. The number of 92 
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samples with Corynebacterium spp., sample type, and the results of antibiotic 93 
susceptibility testing (AST) were analyzed using the database of the Institute of 94 
Medical Microbiology, University of Zurich in Switzerland. According to the current 95 
guidelines by the Infectious Disease Society of America (IDSA) (13), we classified 96 
bacteria as a relevant pathogen, when the same species was cultured in ≥ 2 97 
samples and as a contaminant when a species was detected in only one of ≥ 2 98 
samples (2). Cases with only one sample per diagnostic set were excluded for 99 
further analysis, as a distinction between infection and contamination was not 100 
possible in those cases. Patient’s clinical and demographic parameters and medical 101 
history including time of diagnoses and follow-up were investigated using the clinical 102 
database of the orthopedic hospital and the database of the Infectious Diseases 103 
Consultation service of the University Hospital of Zurich. We grouped patients with 104 
an infection into two groups as followed: i) monobacterial Corynebacterium sp. 105 
infection, ii) or as part of a polymicrobial infection (Corynebacterium sp., and at least 106 
another pathogen in ≥ 2 samples). Clinical parameters of symptoms such as fever, 107 
redness, swelling, and presence of sinus tract at infection site were reviewed. 108 
Patients with an infection were grouped as associated with joint arthroplasty (PJI) or 109 
another orthopedic implant (implant-associated infection), as foot or pressure ulcer 110 
with or without osteomyelitis, septic arthritis without foreign material, or deep soft 111 
tissue infection associated with surgery. An osteomyelitis was defined when 112 
histopathology confirmed acute (presence of neutrophils) or chronic osteomyelitis 113 
(presence of bone necrosis or sequester), when bone biopsies showed growth of 114 
Corynebacterium sp., or when osteomyelitis was assumed with magnet resonance 115 
imaging (MRI). 116 
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In the control group of blood-stream infections, we diagnosed an infection when 117 
either ≥ 2 blood cultures were positive with the same Corynebacterium sp., when 118 
only 1 blood culture plus a vascular catheter was positive and sepsis criteria were 119 
fulfilled.  120 
The study was performed in line with the current ethical guidelines and approved by 121 
the Institutional Review Board in Zurich, Switzerland (KEK Nr. 2016-00145).  122 
Microbiological methods 123 
Pre-diagnostic and diagnostic processing was done as previously described (14). 124 
From 2006 to 2011, Gram-positive rods were identified by an in house standard 125 
scheme by means of biochemical (15). From 2012 on, strains were identified using 126 
matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-127 
TOF MS) using a Bruker MALDI Biotyper as described elsewhere (16) Reference 128 
database V.3.3.2.0 (3995 entries) or later database versions were applied with a 129 
species cut-off of 1.7 (16, 17). If no or ambiguous identification was achieved by 130 
biochemical characterization or MALDI-TOF MS, respectively, and a Gram-positive 131 
rod was isolated in more than one sample or from a normally sterile fluid, the 132 
identification was confirmed by 16S rRNA gene sequence analysis (18). 133 
Corynebacterium spp. that could not be assigned to species level due to high 134 
homology of 16S rRNA gene sequences, were identified on genus level as 135 
Corynebacterium sp. (19). 136 
Screening for antimicrobial susceptibility was performed by disc diffusion 137 
tests on Mueller-Hinton agar (Becton Dickinson, Cockeysville, MD) supplemented 138 
with 5% sheep blood before 2011 and on Mueller-Hinton agar (Becton Dickinson) 139 
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supplemented with defibrinated horse blood and 20 mg/L beta-NAD (MH-F) from 140 
2011 on; zone diameters were interpreted according to CLSI guidelines for 141 
staphylococci as closest surrogate for corynebacteria before 2011 (20), according to 142 
EUCAST breakpoints for staphylococci from 2011 to 2013 and according to 143 
EUCAST guidelines for corynebacteria from 2014 on (21). For this study, zone 144 
diameters of the period 2011-2013 were reinterpreted retrospectively according to 145 
the latest EUCAST guidelines for corynebacteria (21). MIC testing by Etest was done 146 
for relevant Corynebacterium isolates and single drugs to confirm disc diffusion tests 147 
and for strains with poor growth throughout the study period (data not shown). 148 
Statistical analysis 149 
Categorical data were tested for differences using Fisher’s exact or chi-150 
squared tests, as appropriate, whereas continuous variables were tested using 151 
Wilcoxon rank sum tests. Two-tailed P-values <0.05 were considered statistically 152 
significant.  153 
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RESULTS 154 
Corynebacterium strains and variation. We identified 128 Corynebacterium sp. 155 
isolates in 97 cases at the Orthopedic University Hospital Balgrist between 2006 and 156 
2015 (Figure 1). The median age of all inlcuded patients was 66 years (range, 9-86 157 
years) with a predominance of men (67%), in the patients with an infection, the 158 
median age was 54.5 years (range, 25-83 years), 56.3% of them were male. Most 159 
commonly, Corynebacterium tuberculostearicum (n=26), Corynebacterium 160 
amycolatum (n=17), Corynebacterium striatum (n=13), or Corynebacterium 161 
afermentans (n=11) were found as the single pathogen in 97 cases with suspected 162 
orthopedic infections (Table 1). In 13 cases, identification of Corynebacterium to 163 
species level was not available. In two cases, two different Corynebacterium sp. 164 
were cultivated in the same diagnostic set. 165 
For 31 out of 97 cases we could not distinguish between infection and contamination 166 
as only one diagnostic sample was sent to microbiological analysis. Among the 167 
remaining 66 cases with ≥2 samples, we identified 16 cases (24.2%) with an 168 
infection due to Corynebacterium sp., in 50 cases only one samples was positive in 169 
culture and thus considered a contamination. 170 
Of 66 cases the median number of analyzed samples per case was four (range 2-171 
11); in the cohort of 16 infections, the median was 5 (range 2-8) with a mean 172 
positivity of 67.8% (SD ± 28.8%). 173 
Infections were associated with a native (n=1, 6.3%) or prosthetic joint (PJI, n=4, 174 
25%), an orthopedic implant other than joint prosthesis (n=5, 31.3%), a deep foot or 175 
pressure ulcer (n=4, 25%), or deep postsurgical soft tissue infection (n=2, 12.5%) 176 
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(Supplementary Table 1). All infections sites were found at the lower extremities (feet 177 
n=7, knee n=5, hip n=3, and gluteal n=1). Knee arthroplasty was involved in 75% 178 
(n=3) of the PJI cases.  179 
Typical inflammatory signs including redness, pain, or swelling were present in the 180 
majority (n=10, 62.5%) of the infections. Among the four cases diagnosed with PJI, 181 
all presented as chronic infections with a sinus tract after a prolonged wound 182 
healing. Within the four patients with deep ulcer diagnosis, acute osteomyelitis was 183 
additionally diagnosed. 184 
Nine out of 16 infections (56.3%) were diagnosed as a polymicrobial infection 185 
including the four patients with ulcer diagnosis. In addition to corynebacteria, 186 
staphylococci, streptococci, and Enterobacteriaceae were recovered most frequently 187 
form polymicrobial samples. Monobacterial infections (n=7) were either caused by C. 188 
striatum (n=3), C. tuberculostearicum (n=1), C. amycolatum (n=1), Corynebacterium 189 
ureicelerivorans (n=1), or a Corynebacterium sp. (n=1), which could not further be 190 
specified even after sequencing of the strain. Supplementary Table 1 summarizes all 191 
mono- and polymicrobial infections grouped according to infection diagnosis. 192 
The majority of the infections were diagnosed while already taken antibiotics (n=9). 193 
Antibiotic treatment widely differed on the one hand due to different pathogens of the 194 
mostly polymicrobial infections but on the other hand due to different antimicrobial 195 
susceptibility testing results of isolated Corynebacterium spp.  196 
Surgical treatment was debridement (in presence of an implant with retention of the 197 
implant) in five, definitive removal of the implant in five, amputation in four, and an 198 
exchange of the implant in two cases. Since all PJI presented with a sinus tract as a 199 
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sign of chronic infection, an aggressive surgical treatment was chosen from the 200 
beginning with either a two-stage exchange in two, definitive removal of the 201 
prosthesis (girdlestone) in one, and amputation in one patient. 202 
The Corynebacterium species spectrum in 97 orthopedic cases was different from 203 
the spectrum of 70 cases with 86 positive blood culture samples isolated in patients 204 
with suspected bloodstream infections. In blood cultures, the diversity of 205 
corynebacteria seemed broader with a predominance of Corynebacterium jeikeum 206 
that was not detected in orthopedic samples, and with significantly less C. striatum 207 
and C. tuberculostearicum compared to orthopedic cases (Table 1). 208 
AST. Susceptibility testing was done in 62 out of 128 (48.4%) orthopedic 209 
Corynebacterium isolates and 64 out of 70 (91.4%) blood culture isolates (Table 2). 210 
Percentage of susceptible orthopedic Corynebacterium isolates were 72% for 211 
gentamicin, 28% for penicillin, 81% for tetracycline, 100% for vancomycin, 44% for 212 
ciprofloxacin, 6% for clindamycin, 100% for linezolid and 82% for rifampin using 213 
EUCAST breakpoints (2011-2015). Rates of susceptibility of corynebacteria isolated 214 
from orthopedic samples and of isolates from blood cultures were comparable (Table 215 
2, data of rates are not shown). Supplementary Table 2 shows susceptibility testing 216 
results of the four most commonly isolated Corynebacterium spp. in orthopedic 217 
patients. All isolates were susceptible to vancomycin and linezolid. In contrast, 218 
penicillin resistance was observed in 78% of C. tuberculostearicum, in 80% of C. 219 
amycolatum, in 100% of C. striatum, and in 62% of C. afermentans. Tetracycline, 220 
ciprofloxacin, clindamycin, rifampin, and gentamicin showed variable frequencies of 221 
resistance among different species. Susceptibility testing of corynebacteria isolated 222 
between 2006 and 2010 was done according to CLSI recommendations. Rates of 223 
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susceptible isolates for gentamicin and vancomycin were similar when results of the 224 
years 2006 to 2010 (CLSI criteria) and of the years 2011 to 2015 (EUCAST criteria) 225 
were compared. For penicillin and tetracycline, a significantly lower rate of 226 
susceptibility was observed using EUCAST interpretive criteria (2011-2015) 227 
compared to CLSI (p=0.005, p=0.04, respectively) (see Table 2).   228 
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DISCUSSION 229 
Our study identified a provenorthopedic infection due to Corynebacterium sp. in only 230 
24.2% of the cases in whom a Corynebacterium sp. had been isolated over a period 231 
of 10 years. The same phenomena was observed in patients with positive blood 232 
cultures with a proved infection in only 24.3%. We found that implant-associated 233 
infections and ulcers with or without osteomyelitis were the most common diagnosis 234 
in orthopedic patients as previously described (22).  235 
The Corynebacterium spp. isolated from orthopedic samples differed from the 236 
species spectrum isolated from blood culture samples. We found 26 orthopedic 237 
cases with C. tuberculostearicum. This  typical inhabitant of the skin is often 238 
described in association with intravascular catheter associated infection (12) but 239 
rarely with orthopaedic infections (11). C. striatum was found more frequently in 240 
orthopedic samples as compared to blood culture samples (13.4% vs 2.9%) and 241 
counted for three monomicrobial infections (two implant-associated infections and 242 
one septic arthritis). In the literature, C. striatum is associated with foreign-body-243 
associated infections, infective endocarditis, pulmonary infections, septic arthritis, 244 
and ventilator tubes in hospital settings (12, 23, 24). C. jeikeium was recoverd in 245 
20% of our Corynebacterium positive blood cultures but not in any of the orthopedic 246 
samples. C. jeikeum has been described as cause of endocarditis, bacteremia, 247 
cerebrospinal fluid shunt infections, peritoneal dialysis peritonitis and rarely as cause 248 
of PJI (11, 25, 26). Biochemical characteristics and cell envelope structure are key 249 
factors for the adaption to a certain habitat or body site predilection. Lipophilic 250 
corynebacteria are part of the human skin flora but can invade deep tissue after 251 
surgery for example. In contrast, we also described invasive infections with non-252 
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lipophilic corynebacteria (C. aurimucosum, C. simulans, and C. striatum). The 253 
pathogenesis of these infections is not yet explained. 254 
Identification of corynebacteria to species level is challenging and often requires 16S 255 
rRNA and rpoB gene sequencing and/or nowadays MALDI-TOF MS analysis in 256 
addition to morphological and biochemical characterization (16-18, 27). Before 2012, 257 
the identification of corynebacteria to species level by biochemical identification 258 
followed by 16S rRNA gene sequencing was restricted in our laboratory to relevant 259 
Gram-positive rods isolates. In 2012, our laboratory introduced MALDI-TOF MS for 260 
the identification of bacteria; rapid and reliable identification became available for 261 
most Gram-positive rods. However, we do not exclude that we missed infections 262 
before the application of MALDI-TOF MS. 263 
There are no clinical data available on how to best treat Corynebacterium sp. 264 
implant-associated infections. AST has to be performed on all Corynebacterium 265 
isolates causing orthopedic infections if antibiotics other than vancomycin are given 266 
(28-30). We found that only 20 to 38% of the isolated C. tuberculostearicum C. 267 
amycolatum, and C. afermentans were susceptible to penicillin and none of the C. 268 
striatum. Clindamycin, ciprofloxacin, gentamicin, rifampin, and tetracycline were not 269 
regularly effective against these corynebacteria making vancomycin the only valid 270 
empiric treatment until susceptibility testings are performed. Variable resistances 271 
were observed in different Corynebacterium spp. as already shown in the study by 272 
Reddy et al. who observed a high frequency of penicillin resistant strains (>50%), as 273 
well as erythromycin, clindamycin and gentamicin resistant strains (31). Further 274 
studies are needed to investigate combination antibiotic treatment , e.g. a quinolone 275 
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plus rifampicin, for treatment of implant-associated infections as is currently routinely 276 
used for treating other Gram-positive infections such as staphylococci (1). 277 
Guidelines on how to perform and interpret AST of corynebacteria are sparse. 278 
CLSI provides clinical breakpoints (CBP) for broth microdilution of corynebacteria 279 
since 2006; EUCAST published CBPs for microdilution and disk diffusion methods in 280 
2014. CLSI and EUCAST both defined CBPs for all Corynebacterium spp. (for MIC 281 
and/or zone diameter) based on small numbers of each Corynebacterium sp. or 282 
even inferred breakpoints from staphylococcal CBP (i.e. CLSI criteria for gentamicin, 283 
vancomycin and tetracycline); in particular, EUCAST defined clinical breakpoints 284 
without defining epidemiological cutoffs (ECOFFs) separating the wild type 285 
population from the strains with a resistance against a given antibiotic 286 
(http://www.eucast.org/clinical_breakpoints/, update 03/2017). The breakpoints of 287 
CLSI and EUCAST and as a consequence the rates of susceptible and resistant 288 
isolates may therefore differ significantly. From 2006 to 2010, we used CLSI 289 
staphylococcal breakpoints for zone diameters due to the lack of breakpoints specific 290 
for corynebacteria. Penicillin susceptibility was observed in 65% of the isolates. In 291 
contrast, applying the EUCAST corynebacteria breakpoints resulted in only 28% 292 
susceptible isolates. This shift was mainly caused by a change of the antibiotic discs 293 
used switching from 10 units penicillin (CLSI) previously to currently 1 unit penicillin 294 
(EUCAST). It will be necessary to collect more data on corynebacteria so that 295 
breakpoints can be defined for each species individually based on the distribution of 296 
zone diameters and MICs of strains without acquired resistance.  297 
Our observation that Corynebacterium sp. rarely belongs to an infection when 298 
isolated on an orthopedic ward is only a single hospital report and may not represent 299 
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experiences at other sites. However, it is also mentioned in the report of Cazanave 300 
et al. that Corynebacterium spp. are only occasional causes of PJI as a typical 301 
orthopedic infection (11). The strength of our retrospective analysis is the long 302 
observation period of 10 years in a large orthopedic center. We might have missed 303 
some infections due to our strict definition of at least two positive diagnostic samples. 304 
In patients with foot ulcers, often only one bone biopsy was taken for microbiology 305 
and histopathology and thus the numbers we present are most probable an 306 
underestimation. Nevertheless, our study highlights that isolation of Corynebacterium 307 
spp. in orthopedic patients rarely indicates an infection even when isolated in more 308 
than one sample. However when diagnosed, Corynebacterium spp., infections are 309 
often polymicrobial. It is crucial to test antimicrobial susceptibility of clinically relevant 310 
Corynebacterium spp. since resistance varies between different species. It remains 311 
to be investigated under which conditions corynebacteria change from a commensal 312 
to an invasive pathogen. 313  o
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TABLES AND FIGURES 422 
Table 1. Variation of Corynebacterium spp. strains isolated in 97 patients with suspected orthopedic infections (thereof 16 423 
individuals had a proofed infection) as compared to Corynebacterium spp. strains recovered from blood cultures from 70 424 
patients with suspected blood-stream infections (of these 17 had a proofed infection).  425 
Microbiological characteristics No. (%) of patients 
with positive 
orthopedic isolates * 
No. (%) of patients 
with positive blood 
cultures  
P-value No. of 
orthopedic 
infections 
No. of blood-
stream infections 
Total N=97 N=70  N=16 N=17 
C. accolens 1 (1.0) 1 (1.4) 1.0 0 1 
C. afermentans 11 (11.4) 8 (11.4) 1.0 0 0 
C. amycolatum 17 (17.5) 11 (15.7) 0.8 3 7 
C. aurimucosum 2 (2.1) 3 (4.3) 1.0 1 0 
C. diphtheriae biovar mitis 1 (1.0) 0 (0)  1 0  
C. glucuronolyticum 1 (1.0) 1 (1.4)  0 0 
C. imitans 0 2 (2.9)  0 0 
C. jeikeium 0 14 (20.0) 0.0001 0 7 
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Microbiological characteristics No. (%) of patients 
with positive 
orthopedic isolates * 
No. (%) of patients 
with positive blood 
cultures  
P-value No. of 
orthopedic 
infections 
No. of blood-
stream infections 
Total N=97 N=70  N=16 N=17 
C. macginleyi 0 1 (1.4)  0 0 
C. minutissimum 1 (1.0) 4 (5.7) 0.162 0 1 
C. mucifaciens 1 (1.0) 4 (5.7)  0 0 
C. pseudodiphtheriticum 1 (1.0) 0 (0)  0 0  
C. propinquum 0 1 (1.4)  0 0 
C. simulans 5 (5.2)) 2 (2.9) 0.700 1 0 
C. striatum 13 (13.4) 2 (2.9) 0.026 3 1 
C. tuberculostearicum 26 (26.8) 3 (4.3) 0.001 3 0 
C. ureicelerivorans 2 (2.1) 0 (0)  1 0 
Corynebacterium sp.  13 (13.4) 13 (18.6)  1 0 
Polymicrobial ** 2 (2.06) 0  2 0 
* Most commonly isolated orthopedic strain spp. are labelled in bold, ** Isolation of two different Corynbacterium spp. strains (one 426 
case with C. aurimucosum/C. amycolatum, one with C. auris/C. aurimucosum)  427 
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Table 2. Antibiotic susceptibility testing (AST) of Corynebacterium spp. isolated between 2006 and 2015.  428 
    
Sample 
origin 
Susceptible isolates (%) 
Species Years CBP1 ERY2 GEN PEN TET VAN CIP CLI LZD RIF 
Corynebacterium 
spp. (n=26) 
2006-
2010 
CLSI Orthopedic 35 85 65 100 100 nd nd nd nd 
Corynebacterium 
spp. (n=36) 
2011-
2015 
EUCAST Orthopedic nd 72 28 81 100 44 6 1003 823 
Corynebacterium 
spp. (n=36) 
2006-
2010 
CLSI Blood culture 22 64 47 92 100 nd nd nd nd 
Corynebacterium 
spp. (n=28) 
2011-
2015 
EUCAST Blood culture nd 61 29 78 100 29 19 1004 884 
1 AST was performed by disc diffusion. Clinical breakpoints (CBP) from CLSI (20) were applied from 2006-2010 and EUCAST CBP 429 
from 2011-2015 (21). 430 
2 ERY, erythromycin; GEN, gentamicin; PEN, penicillin; TET, tetracycline; VAN, vancomycin; CIP, ciprofloxacin; CLI, clindamycin; 431 
LZD, linezolid; RIF, rifampin. 432 
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3 DST data available for LZD and RIF for n=12 and n=17 isolates, respectively. 433 
4 DST data available for LZD and RIF for n=12 and n=17 isolates, respectively. 434 
 435 
FIGURE LEGENDS 436 
Figure 1. Flowchart of 97cases and 128 positive samples in whom Corynebacterium spp. were isolated describing 437 
variation of different species in suspected orthopedic infections, in analysis of antibiotic susceptibility testing (AST), or 438 
clinical characteristics of infections 439 
 440 
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